Member Info for Celtic007

Would the toxicity study really take a year? Like to think not, if money is there. A clearer pathway is needed to be known to all of us. Still very good to have banked all this money.

Do think that both tyk2 molecules will go, to same person, if data good as needed toxicity wise. Both are like twins of each other

look at the two ***boys busy this morning. bless. think simon is the giver and roberto is the acceptor. these brazilian types like being shafted

Potnak, that post makes no sense. You think now CHK1 has 0 value.

Come on. Advisers taking fee on shares , suspicious. Sareum cannot win FFS . I think it's great, they win if we win...all in it. This money coming in is not a stupid investor

Potnak .the other day you said you still thought that chk1 was linked to all our our other two drugs, so whoever wanted that , wanted the rest. Now this post this morning. You are becoming so obvious. At least bluenose, been clear he wants this down so can buy. You really are a disappointment here.

Sad to see

Great news. Always said why leave the one, and take the other. more money coming In ..lovely jubbly

Appreciated PCS

Hi pcs. Hope you are ok. Why do you think this extra toxicity trial is being done?. Is it mandatory as part of the trial process, or something we overlooked or something worrying or something a pharmaceutical company has asked for?

Seems a lot of confusion around this bit.

Thanks again to you and others for your research.

what a twat you both *** boys are roberto and simon. shorting just up your alley. fit right at home at p diddy.

Roberto really is a twat .. the shorts are closing sonny.

Hi abyer. Hope you are ok. I agree with that point, we need more clarity from the board. Is this part of the normal requirement or something we missed or a requirement from a potential license partner.

Great post bobbler. Anyone putting money in now, at this conjuncture knows how risky it is as boom or bust stage. They will have looked at the data that exists and be happy.

If pharmaceutical are playing hardball and we excepted a really daft deal then we would all be going mental. Trust the board. They know the molecules and their worth.

The RNS was a very positive one, no issues with data of a major concern. A individual or individuals has put a good amount of money in and are confident. We are moving forward. Let's see where our chk1 takes us, hopefully positive news soon.

roberto now with all your bile, you are making ****** jokes about the ceo english. ironic considering your username

. desperate sonny.

Potnak, someone was good enough to explain this morning this is all normal regarding the trials needed. My god, you seen so down. I know you expected this to fall badly last week and must be annoyed and irritated at the increase since then. Hard when you wanting to have your cake and eat it.

Thanks sadoldgit.

Great start. Lots of buying. The RNS stated great biological marker set, that I think has gone unnoticed by a lot. In drug discovery that is fundamentally important.

Yep agree Lazarus. If sareum want this and the partner wants to to give this, then the partner will say under what conditions they will give what we want . More data to endure it is a safe drug over a longer period.

I also noted that a strong biological marker. Was noted....very important as sadoldgit has suggested. Shows it's doing positive stuff to immune

i agree 100 💯, these guys are not fools. especially after our ****ups with rf.

The money they have got in from these investors is a good amount and no way will these investors put in money without having done their due diligence. Remember the RF scenario will be known by them so they would have been ultra cautious.

Let's get this data collected and then as we say the price will go up, as another obstacle cleared.